Sam68 phosphorylation correlates with Fyn but not Lck expression in T cells. This substrate has been used here to explore the possible basis of the specificity of Fyn versus Lck. We show that this specificity is not based on a spatial segregation of the two kinases, since a chimeric Lck molecule containing the membrane anchoring domain of Fyn does not phosphorylate Sam68. Moreover, a Sam68 molecule targeted to the plasma membrane by the farnesylation signal of c-Ha-Ras remains poorly phosphorylated by Lck. In T cells, Fyn appears to be the active Src kinase in rafts, but Sam68 is not expressed in rafts, and its distinct phosphorylation by Fyn and Lck is not affected by raft dispersion. The Fyn/ Lck specificity does not reflect a higher kinase activity of Fyn in general, as both Fyn and Lck are similarly recognized by an anti-active Src antibody. Both also strongly phosphorylate another Src substrate in vivo. Mainly, Lck phosphorylates Sam68 when the interaction between the SH3 domain and the SH2-catalytic domain linker is altered in heterologous Src molecules or after mutating key residues in the linker that increase the accessibility of the SH3 domain. Thus, the distinct potential of Fyn and Lck to phosphorylate Sam68 is likely controlled by the interaction of the kinase SH3 domain with the linker and Sam68, possibly on a competitive binding basis.
Introduction
T cells express primarily two Src protein tyrosine kinases (PTKs), Lck and Fyn, both of which are likely fundamental in signal transduction after T cell receptor (TcR) ligation. However, their distinct role in the initiation of the T cell activation cascade is still unclear. They are probably not or only partially redundant since studies of mice or T cell lines defective in Lck or Fyn have shown a different phenotype in T cell development and T cell activation (Appleby et al., 1992; Groves et al., 1996; Molina et al., 1992; Stein et al., 1992; van Oers et al., 1996) . In addition, an increasing number of proteins has been found to interact with and/or to be phosphorylated specifically by Fyn (da Silva et al., 1997; Feshchenko et al., 1998; Marie-Cardine et al., 1997; Marie-Cardine et al., 1998 Qian et al., 1997; Tsygankov et al., 1996) or by Lck (Takemoto et al., 1995 (Takemoto et al., , 1996 in vivo. Furthermore, Lck and Fyn catalytic activities in T cells appear to be differently regulated depending on their localization in plasma membrane microdomains (Kabouridis et al., 2000) .
Src PTKs are thought to be regulated mainly by the phosphorylation state of two critical tyrosine residues, one within the C-terminal tail (Tyr527 in Src) and the other within the kinase domain in the so-called Src autophosphorylation motif (Tyr416 in Src) (Cartwright et al., 1987; Cooper et al., 1986; Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 1987) . It is currently believed that the PTKs are in an active state when the tyrosine in the Src autophosphorylation site is phosphorylated. As for the C-terminal tail tyrosine residue its phosphorylation by Csk Okada et al., 1991) (and/or CHK; not in T cells) (Davidson et al., 1997; Klages et al., 1994) inhibits the kinase activity, whereas its dephosphorylation by tyrosine phosphatases, such as CD45 in T cells (Mustelin et al., 1989, Mustelin and Altman, 1990) , has the opposite effect. Structural data from crystallization of the Src, Hck, and Lck proteins Xu et al., 1997; Yamaguchi and Hendrickson, 1996) together with a large body of mutational analyses have illustrated how phosphorylation of this distal tyrosine residue controls the conformation of the kinase by interacting with its own SH2 domain. However, they also demonstrated that Src-family kinases are maintained in an inactive and closed conformation by intramolecular binding of the SH3 domain to the linker between the SH2 domain and the catalytic domain (SH2-CD linker). Accordingly, displacements of these two interactions seem to participate in the regulation of Src PTKs activity (Alexandropoulos and Baltimore, 1996; Hartley et al., 1999; . Whether these interactions are differently regulated between Fyn and Lck is unknown but one can assume that this may also contribute to the different behaviour of the two Src PTKs in T cells.
Of concern with this problem is the phosphorylation of Sam68 in T cells. Sam68 is a 68 kDa protein first reported to associate with and to be strongly phosphorylated by Src during mitosis (Fumagalli et al., 1994; Taylor and Shalloway, 1994) and to regulate cell growth (Barlat et al., 1997) . Sam68 is actually classified as a member of the GSG family protein (GRP, Sam68, Gld-1) whose function might be to link the nuclear export of mRNA to signaling events (Vernet and Artzt, 1997) . The molecule also has several proline-rich regions and a tyrosine-rich C-terminal region allowing it to interact with the SH3 domain of Src PTKs, and, once phosphorylated, with various SH2 domain containing signaling molecules suggesting an adapter function (Jabado et al., 1998; Richard et al., 1995 ) . Others and ourselves previously reported that Sam68 was constitutively phosphorylated in various T cell lines (Fusaki et al., 1997; Lang et al., 1999) . This phosphorylation was probably linked to the high level expression of Src PTKs in transformed T cells. However, it was found that, for unknown reasons, this constitutive phosphorylation of Sam68 correlates with Fyn levels, but not with Lck expression (Lang et al., 1997 (Lang et al., , 1999 . Investigating this issue, we show in the present work that the inability of Lck to phosphorylate Sam68 in vivo can be bypassed by altering the conformation of the kinase through modifications of SH3/SH2-CD linker interactions.
Results

A different localization of Fyn and Lck is not involved in the specific phosphorylation of Sam68 by Fyn in T cells
Fyn but not Lck fully phosphorylated Sam68 in T cells (Lang et al., 1999) . A difference in their localization might be responsible, as Fyn was suggested to be expressed not only at the cell membrane, like Lck, but also in the centromeric region (Ley et al., 1994) . Both PTKs contain at the N-terminus, within the so-called SH4 domain, a glycine residue and cysteine residues that are subjected to myristoylation and palmitoylation, respectively, and control their binding to membranes and subsequent localization. We thus constructed a molecule in which the first 10 a.a. of Lck were replaced with those of Fyn, and analysed Sam68 phosphorylation induced by this chimeric PTK (Figure 1a ). Fyn induces a strong phosphorylation of Sam68. In contrast, like wild-type Lck, the N-ter Fyn/ Lck chimera did not trigger any significant phosphorylation of the molecule. Note that unidentified proteins around 100 and 110 kDa (see also Figure 3b ) were also specifically phosphorylated by Fyn. Figure 1b We next used a complementary approach by targeting Sam68 at the plasma membrane using its cDNA, deleted of the nuclear localization signal, fused to enhanced green fluorescent protein (GFP) and the farnesylation signal of c-Ha-Ras (GFP-F). GFP-F alone gave a homogeneous membrane pattern in fluorescence microscopy. Sam68-GFP-F was also localized at the cell membrane (Figure 2a) . The molecule accumulated in membrane patches in most cells. This phenomenon may be driven by the previously reported propensity of Sam68 to multimerize (Chen et al., 1997) . Mainly, as with wild-type Sam68, only Fyn strongly phosphorylated Sam68-GFP-F after cotransfection (Figure 2b ). These data likely exclude that a particular localization of Fyn outside the plasma membrane might account for its specific role. 
Sam68 phosphorylation is not dependent on membrane rafts
Fyn and Lck are expressed inside and outside lipid rafts at the cell membrane. However, while Fyn is active in both compartments, Lck appears to encounter inhibitory conditions in these microdomains (Kabouridis et al., 2000) . This might explain the difference between the two Src PTKs to phosphorylate Sam68 if this metabolic process occurs in rafts. Thus, we analysed Sam68 expression in rafts. Immunoblotting showed Sam68 absent from the low-density fractions, which contain rafts, but within the lower-most detergent-soluble fractions ( Figure 3a ). Sam68 expression in these fractions was expectedly low as we reported that the protein was not abundant in T cell membranes (Lang et al., 1999) . Blotting with anti-LAT, a protein enriched in T cell rafts, was used as a control. We next assessed the effects of raft disruption by incubating cells overexpressing Fyn or Lck with methyl-b-cyclodextrin (MbCD) that depletes membrane cholesterol and destroys rafts (Ostermeyer et al., 1999) . No significant changes in Sam68 phosphorylation by Fyn were observed in treated cells and Lck remained ineffective in phosphorylating Sam68 ( Figure  3b ). Note that we controlled in parallel experiments that rafts have been destroyed by MbCD treatment since LAT was no more detectable by Western-blot in the lowdensity fractions (not shown).
Overexpressed Fyn and Lck present similar activity in vivo
The catalytic activity of Src PTKs is controlled in vivo by complex mechanisms not yet completely understood. Hence, speculations can be made about a higher activity of overexpressed Fyn resulting in an increased Sam68 phosphorylation in vivo. To explore this, we first used an anti-active Src Ab against the phosphorylated form of the activation loop on residue Y418. This loop is conserved between Src and Fyn, and only differs by a single substitution (Q?E) at position 399 in Lck. Using recombinant Lck, we first verified that this Ab specifically recognized the active form of the molecule in vitro (data not shown). We next probed in blotting experiments cells transfected with Fyn or Lck with the anti-active Src Ab. Several bands were strongly recognized in both cell extracts ( Figure 4a , left panel). Immunoprecipitation with the anti-Src pY418 Ab followed by blotting with anti-Fyn or anti-Lck Abs were also performed ( Figure 4a , right panel). The results suggested that Fyn was only one of the three major bands recognized in whole cell lysates by the anti-active Src Ab. In contrast, most bands precipitated in Lck-transfected cells were blotted by the anti-Lck Ab. To further confirm this substantial phosphorylation of the activation loop in Lck, the spatial distribution and levels of the active PTKs in Lck-and Fyn-transfected cells were compared by fluorescence microscopy ( Figure 4b ). Fyn-and Lckspecific Abs strongly labeled the plasma membrane of cells overexpressing the corresponding kinase with similar intensities. Mainly, we also observed a similar recognition level and fluorescence distribution at the plasma membrane with the anti-Src pY418 Ab in cells transfected with either PTKs. Note that this last staining was very low in non transfected cells (not shown). We concluded from these results that the phosphorylation status on residue Y418 in the activation loop between Lck and Fyn was very similar.
To check more directly the in vivo catalytic activity of Lck, the phosphorylation in Jurkat cells of Dok-1 was also examined. Dok-1 is a privileged substrate of the PTK Abl, also phosphorylated by Src in transformed fibroblasts. Moreover, Dok-1 is a substrate of Lck in T cells (Nemorin and Duplay, 2000; Yang et al., 1999) . We thus speculated that an altered kinase activity of overexpressed Lck in vivo would also be apparent with this substrate. Strikingly, Figure 4c shows that, contrary to Sam68, both Fyn and Lck phosphorylated Dok-1.
Lck is able to phosphorylate Sam68 when the interaction between the SH3 domain and the SH2-CD linker is altered Sam68 was initially described as a binding partner for Src PTKs SH3 domains through its proline-rich motifs (Shen et al., 1999) , a required interaction for the molecule to be phosphorylated. In inactive Src PTKs, the SH3 domain binds the region linking the SH2 domain to the catalytic part of the molecule (the socalled SH2-CD linker), which adopts a polyproline type II helix conformation (Xu et al., 1999) . However the contacting a.a. in the linker are quite different between Fyn (and Src) on the one hand and Lck on the other ( (Williams et al., 1998) , see also Discussion). We thus made the hypothesis that the distinct phosphorylation of Sam68 by Fyn and Lck may be explained on a competitive binding basis between its proline-rich motifs and the SH2-CD linker for the SH3 domain of the corresponding kinase.
To evaluate this point, different constructs were established in which this intramolecular interaction was altered (Figure 5a ). We first generated a chimeric molecule, Fyn/Lck(SH2+CD), in which the Cterminus of Lck, including the SH2 domain and the catalytic domain, was fused to the N-terminus of Fyn. In this kind of molecule, the SH3 domain is unlikely to adapt to the heterologous SH2-CD linker. As shown Figure 5b , the chimera was able to phosphorylate Sam68 as efficiently as wild-type Fyn. We next used a molecule, Src(SH3)Lck, in which the SH3 domain of Src has been substituted by the SH3 domain of Lck. We knew from preliminary experiments that wild-type Src triggered, like Fyn, a strong phosphorylation of Sam68 in Jurkat cells. Clearly, Src (SH3)Lck was as efficient as wild-type Src to phosphorylate Sam68 (Figure 5c ), suggesting that the SH3 Lck domain can fully substitute to the one of Src when it is not facing the homologous SH2-CD linker. This assumption was then directly checked with an Lck molecule, Lck K232E/P233G, mutated on the two essential residues in the SH2-CD linker to contact the SH3 domain. Sam68 was strongly phosphorylated by the mutated PTK (Figure 5d ). We conclude that the interplay between the SH2-CD linker of Lck and its SH3 domain is probably essential to explain the lack of ability of the PTK to phosphorylate Sam68 in vivo.
Discussion
Sam68 is predominantly present in the nucleus of T cells and its expression outside this cell compartment is low (Lang et al., 1999) . Presumably, the protein shuttles very rapidly outside the nucleus. We reported however that its physiological phosphorylation by Fyn likely occurred in a membrane compartment since a Fyn mutant deleted of its N-terminal SH4 membrane anchoring domain was inactive (Lang et al., 1999) . Thus, the different phosphorylation of Sam68 by Fyn and Lck could be explained first by the presence of a fraction of Fyn in a localization where Lck was missing. A dissimilar distribution of the two Src PTKs at the plasma membrane was also conceivable. In both cases, differences in the SH4 domain may be responsible. However, we show here that a chimeric Lck molecule containing the membrane binding domain of Fyn did not increase Sam68 phosphorylation levels, likely excluding this hypothesis. Nevertheless, the possibility remained of a different catalytic activity of Fyn and Lck at the plasma membrane. Of concern with this conjecture is the recent demonstration that the activity of Lck from lipid rafts in Jurkat T cells is very low, in contrast to Fyn, while both kinases are strongly active outside rafts (Kabouridis et al., 2000) . It has been speculated that Lck activity was more efficiently turned off by the PTK Csk, the main Src PTK regulatory molecule recruited into rafts by the phospho-adaptor Cbp (Itoh et al., 2002; Kawabuchi et al., 2000; Torgersen et al., 2001 ). However, we found that Sam68 was not detectable in rafts and that raft disruption did not strongly affect Sam68 phosphorylation by Fyn or Lck. It is noteworthy that Sam68 fused to the farnesylation signal of c-Ha-Ras remained poorly phosphorylated by Lck. As the fused Ras sequence is farnesylated, this chimera is likely enriched in rafts, as is a full-length cHa-Ras (Prior et al., 2001) , further suggesting that Sam68 is highly phosphorylated by Fyn and poorly phosphorylated by Lck regardless of its localization inside or outside rafts. To directly investigate the in vivo catalytic activity of overexpressed Fyn and Lck molecules, experiments were also undertaken using an Ab against a phosphopeptide corresponding to the conserved Src activation loop. We found a similar recognition of transfected Fyn or Lck molecules, suggesting that a significant fraction of the PTKs was in an active form. These results cannot be considered as a formal proof that they have exactly the same activity. They nevertheless suggest no large difference. This conclusion was further strengthened by our experiments with the adaptor Dok-1. Taken together, these data are strongly indicative that the differential phosphorylation of Sam68 by Fyn and Lck in T cells is not due to a globally decreased ability of Lck to phosphorylate substrates inside the cell membrane. Instead, they suggest that some intrinsic properties of the two PTKs are involved. Crystallographic data have shown that in the inactive form of Src PTKs, the SH2-CD linker interacts with the SH3 domain, maintaining the molecule in a 'closed' conformation. It has also been reported that SH3 domain polyproline ligands are able to displace this interaction in vitro as shown for Nef , Sin (Alexandropoulos and Baltimore, 1996) and Tip (Hartley et al., 1999) . This process is likely required for substrates like Sam68 to be phosphorylated in vivo. Indeed, both deletion of proline motif I in human Sam68 (Shen et al., 1999) (the protein encodes at least five distinct polyproline sequences numbered from I to V) and III and IV in its murine homologue (Richard et al., 1995) as well as mutations inactivating the SH3 domain strongly altered Sam68 phosphorylation by Fyn or Src. Src PTKs belong to a very homogeneous family of proteins. However, they exhibit some significant differences in their primary sequence that have been used to distinguish two phylogenic groups, A and B (Williams et al., 1998) . Fyn and Src are in group A while Lck is in group B. Interestingly, these two groups notably differ in the interacting region between the SH3 domain and the SH2-CD linker. Moreover, the SH3 domains of the different Src kinases have not exactly the same properties (Abrams and Zhao, 1995; Hiroaki et al., 1996) . Hence, we raised the hypothesis that the low phosphorylation of Sam68 by Lck may be caused by a reduced accessibility of its SH3 domain to Sam68. To explore this possibility we constructed mutant molecules in which the interaction between the SH3 domain and the SH2-CD linker was altered, including a Lck molecule mutated on residues K232 and P233. A Src mutated on the corresponding residues (K249 and P250) has been shown to have a constitutively accessible SH3 domain (Gonfloni et al., 1999 (Gonfloni et al., , 2000 . Remarkably, all these mutants strongly phosphorylated Sam68. It is now clear that the SH3/ SH2-CD linker interplay not only commands the interaction of Src PTKs with SH3 substrates but also controls the catalytic activity of the enzyme. Indeed, its disruption is an essential step for the activation of the kinase as the SH3 engagement with the linker controls the aC-helix orientation by maintaining the conformation of the N-lobe of the catalytic domain (Gonfloni et al., , 1999 (Gonfloni et al., , 2000 Moarefi et al., 1997; Williams et al., 1997; Xu et al., 1999) . So, although we have clearly shown that a different PTK activity between the wild-type forms of Fyn and Lck to phosphorylate Sam68 is not involved, one can make the hypothesis that the alteration of the SH3/SH2-CD linker interplay in our Lck mutants participates in the restoration of Sam68 phosphorylation also by improving the kinase activity. However, while the Lck K232E/P233G mutant was much more potent than the Fyn/Lck (SH2+CD) chimera to trigger whole tyrosine phosphorylations, it was usually slightly less effective in phosphorylating Sam68. This ultimately suggests that Sam68 is a good in vivo substrate of Lck providing that the accessibility of the SH3 domain of the PTK is increased.
What final conclusions can be drawn? As mentioned above, probably the most interesting one relies on a model where an in vivo competition could take place between the SH2-CD linker and Sam68 for the SH3 domain. It must be emphasized that in this case both the relative affinity of Sam68 for the SH3 domain and the strength of interaction between the linker and the SH3 domain can be involved. Indeed, we found in parallel experiments using a mammalian two-hybrid system a more potent binding in vivo of Sam68 to the Fyn-SH3 domain than to its Lck counterpart (not shown). However, we cannot exclude that Lck is also hardly unfastened by SH3-binding ligands, restraining the accessibility of substrates to the SH3 domain. This work also raises the question of the respective roles of Fyn and Lck in T cells. Although Fyn has been shown to be able to substitute for Lck in some experimental model (Groves et al., 1996) , Sam68 is not the only example of a protein interacting and/or phosphorylated by Fyn specifically. Other molecules such as Pyk2 (Qian et al., 1997) , c-Cbp (Feshchenko et al., 1998; Tsygankov et al., 1996 ), Fyb (da Silva et al., 1997 , SKAP55 (Marie-Cardine et al., 1997), SKAP-HOM (Marie-Cardine et al., 1998) also showed a privileged relationship with Fyn. Future works will be necessary to know if in these cases also the interplay between the SH3 and the SH2-CD linker is an essential parameter to explain this dissimilar behaviour of the two Src PTKs in T cells.
Materials and methods
Cell culture and transfection
Tag Jurkat cells (JTag) were grown in RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, and 1 mM sodium pyruvate. Transient transfections of Jurkat cells were performed by electroporating (at 320 V, 500 mF) 10 to 20610 6 cells with 20 mg of plasmid DNA. Expression in transfected cells was conducted for 48 h followed by analysis.
Antibodies
The phosphotyrosine mAb 4G10, the rabbit polyclonal Ab specific for LAT and the rabbit polyclonal Ab specific for Fyn were from Upstate Biotechnology (UBI, Lake Placid, NY, USA). The rabbit polyclonal Ab specific for Sam68 used for immunoprecipitation experiments has already been described (Lang et al., 1997) . The rabbit polyclonal Ab specific for the C-terminal region of Lck, the mouse mAb specific for Lck and the polyclonal Ab against the C-terminus of Sam68 used for Western blotting experiments were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The Fyn mAb was from Transduction Laboratories (Lexington, KY, USA). A rabbit antiserum against the C-terminus of Dok-1 (RVGTDKTGVKSEGST) was used for immunoprecipitation. The anti-Dok-1 Ab M-276, purchased from Santa Cruz, was used for immunoblotting. The rabbit polyclonal Abs specific for Src and Src pY418 were from Biosource International (Camarillo, CA, USA). The anti-GFP mAb was purchased from Clontech Laboratories (Palo Alto, CA, USA).
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Plasmids and constructs
Full lengh cDNAs encoding wild-type murine Fyn and Lck in pSRa-puro were already described (Lang et al., 1999) . The cDNA encoding Src (SH3)Lck, in pSGT, was kindly given by Dr G Superti-Furga (European Molecular Biology Laboratory, Heidelberg, Germany). The Fyn(N-ter)/Lck and the Fyn(SH4-SH3)/Lck chimeric mutants were generated by PCR into the pMXI and the pSRa-puro vectors, respectively. The Lck K232E/P233G mutant was generated with Site-directed mutagenesis kit, Quickchange (Stratagene, La Jolla, CA, USA). GFP fused to the farnesylation signal of c-Ha-Ras was amplified by PCR using the EGFP-F vector (Clontech) as a template and inserted into the pEF6/Myc-His B vector (Invitrogen, Groningen, The Netherlands). Sam68 lacking its nuclear localization signal (Lang et al., 1999) was next inserted 3' of EGFP-F. The full length cDNA encoding human Dok-1 in pBluescript SK-, kindly given by Dr Nick Carpino (Cold Spring Harbour Laboratory, New York, NY, USA), was sub-cloned into pSRa-puro.
Western blot and immunoprecipitation
Cells lysis, SDS-polyacrylamide gels and immunoblotting were performed as previously described (Lang et al., 1999) . Peroxidase-labeled goat anti-mouse or goat anti-rabbit antiserum, and an enhanced chemiluminescence system (ECL, Amersham Pharmacia Biotech) were used for blotting. For immunoprecipitations, cell lysates (800 mg) were incubated for 2 h at 48C with 5 mg of protein A-Sepharose beads (Amersham Pharmacia Biotech) previously incubated 2 h at 48C with the appropriate Ab. After four washes, immune complexes were boiled and analysed by Western blot.
Fluorescence analysis
For fluorescence microscopy analysis of GFP, cells were directly observed in their culture medium on a glass coverslip mounted on 35 mm Petri dishes in a final volume of 100 ml. Immunofluorescence analysis with the anti-active Src Ab or Abs against Fyn and Lck were performed on paraformaldehyde-fixed cells as previously described (Lang et al., 1999) , using a FITC-conjugated F(ab') 2 fragment donkey anti-rabbit IgG or a rhodamine-conjugated F(ab') 2 fragment goat antimouse IgG (Jackson ImmunoResearch Laboratory, Inc., West Grove, PA, USA) as secondary Abs. Fluorescence microscopy was performed with a Nikon Eclipse TE300 inverted microscope equipped with fluorescein filters using a 660 oil objective. Fluorescence images were collected with a cooled CCD camera (CoolSNAPfx, Roper Scientific, Evry, France) and the MetaMorph Imaging software (Universal Imaging Corporation, West Chester, PA, USA). Quantitative analysis of fluorescence in cells overexpressing PTKs was performed on 12-bit images, using a threshold to eliminate the untransfected cells, and by measuring the intensity of the fluorescence using MetaMorph.
Raft analysis
For purification of rafts, cells (2610 7 ) were lysed for 40 min on ice in 700 ml of 0.5% Triton X-100 in MNE buffer (MES 25 mM, NaCl 150 mM, EDTA 2 mM), dounced 10 times, and mixed with 700 ml 85% sucrose in MNE buffer after removal of large debris by a 10 min centrifugation at 450 g. After transfer to a centrifuge tube, the suspension was overlaid with 1.4 ml 30% sucrose in MNE buffer and 700 ml 5% sucrose in MNE. After centrifugation for 18 h at 200 000 g, 280 ml gradient fractions were collected from the top of the gradient and precipitated with trichloroacetic acid before boiling in sample buffer. For treatment with MbCD cells were incubated with 10 mM MbCD in RPMI HEPES 20 mM for 15 min at 378C. Cell lysates were prepared for immunoprecicipitation and Western blotting as above.
